Subscribe Us

header ads

Recents

header ads

Electrophysiology Devices Market Size, Growth, Demands Outlook and Forecasts to 2032

Precedence Research - December 21, 2022

According to the research report, the global electrophysiologydevices market size is expected to touch USD 10.72  Billion by 2027, from USD 5.54 Billion in 2022, growing with a significant CAGR of 8.6% from 2020 to 2027. 

Electrophysiology Devices Market Size 2020 to 2027

The electrophysiology devices market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global electrophysiology devices market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global electrophysiology devices market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global electrophysiology devices market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1100

 Report Scope of the Electrophysiology Devices Market

Report HighlightsDetails
Market SizeUSD 10.72 Billion by 2027
Growth RateCAGR of 8.6% from 2020 to 2027
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2021
Forecast Period2021 to 2027
Segments CoveredIndication, Application, End User, Region

This study covers a detailed segmentation of the global electrophysiology devices market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global electrophysiology devices market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Medtronic Plc
  • Abbot Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & CO. KG
  • Biosense Webster, Inc.
  • Nihon Kohden Corporation
  • GE Healthcare
  • Microport Scientific Corporation
  • Siemens AG
  • Koninklijke Philips N.V.

Market Segmentation

 By Indication

  • Atrial Fibrillation (AF)
  • Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
  • Supraventricular Tachycardia
  • Bradycardia
  • Wolff-Parkinson-White Syndrome (WPW)
  • Others

By Application

  • Diagnostic Devices
    • Diagnostic Electrophysiology Catheters
    • Holter Monitoring Devices
    • EP Mapping & Imaging Systems
    • Electrocardiograph (ECG)
    • Insertable Cardiac Monitors (ICM)
    • Others
  • Treatment Devices
    • Automated external defibrillators (AEDs)
    • Implantable Cardioverter Defibrillators (ICDs)
    • CRT-D
    • CRT-P
    • Catheters
    • Pacemakers
    • Others

By End-User

  • Ambulatory Surgical Centers
  • Hospitals
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Research Methodology

The research methodology adopted by analysts for compiling the global electrophysiology devices market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global electrophysiology devices market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Electrophysiology Devices Market, By Indication

7.1. Electrophysiology Devices Market, by Indication Type, 2020-2027
7.1.1. Atrial Fibrillation (AF)
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Supraventricular Tachycardia
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Bradycardia
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Wolff-Parkinson-White Syndrome (WPW)
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Others
7.1.6.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Electrophysiology Devices Market, By Application

8.1. Electrophysiology Devices Market, by Application, 2020-2027
8.1.1. Diagnostic Devices
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Treatment Devices
8.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Electrophysiology Devices Market, By End-User

9.1. Electrophysiology Devices Market, by End-User, 2020-2027
9.1.1. Ambulatory Surgical Centers
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Electrophysiology Devices Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Indication (2016-2027)
10.1.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.3. Market Revenue and Forecast, by End-User (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, by End-User (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, by End-User (2016-2027)

Chapter 11. Company Profiles

11.1. Medtronic Plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbot Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Boston Scientific Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Biotronik SE & CO. KG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Biosense Webster, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Nihon Kohden Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Microport Scientific Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Siemens AG
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Koninklijke Philips N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments